Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.
Zheng Quan Toh, Beth Temple, Tran Ngoc Huu, Vo Thi Trang Dai, Nguyen Trong Toan, Doan Y Uyen, Kathryn Bright, Lien Anh Ha Do, E Kim Mulholland, Paul V Licciardi
NPJ Vaccines | Published : 2020
This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low- and middle-income countries (LMICs) in Asia considering PCV introduction.
Awarded by Department of Health | National Health and Medical Research Council (NHMRC)
Awarded by Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)